Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

GOP paints a dark picture as 'weaponization' probe begins

Republicans have opened a new inquiry with a brazen attempt to portray the federal government as weaponized against Americans

The Independent UK

Pfizer, George Soros and Robert Mueller: GOP’s ‘weaponisation’ hearing goes after an array of conservative boogeymen

A committee hearing held as payback for probes into Donald Trump quickly devolved

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

COVID test kits, treatments and vaccines won't be free to many consumers much longer

Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.

WEKU

Haven't had COVID or a vaccine dose in the past six months? Consider getting a booster

Australians aged 18 and over will be eligible for a COVID booster from February 20 if they have not had a vaccine dose or infection in the past six months.

The Conversation

A technicality could withhold RSV shots

A glitch in a law may make it difficult for children from low-income families to get the new RSV vaccine

Salon

Pfizer’s Susan Rienow: from Covid to fighting the ‘silent pandemic’

The pharma giant’s UK chief is adding the company’s voice to scientists’ warnings of the dangers of antibacterial resistance

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

FDA defends vaccine shelf-life extensions

The Food and Drug Administration has said it was following the latest approved safety information when it extended the shelf life of some batches of Pfizer Covid-19 vaccine to 15 months from nine.

Bangkok Post

Sam Smith causes anti-vax Satanic panic

"The Devil. Brought to you by Pfizer..."

Salon

Boebert, Greene, Cruz, others decry ‘demonic’ Grammys

Most Grammy viewers experienced live performances from the nation’s top recording artists Sunday night, but right-wing activists saw a satanic conspiracy theory.

Tribune News Service

The Most Active Stocks to Buy on Wall Street This Week

Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly found takers on Wall Street. Read on….

StockNews.com

‘Thanks Pfizer’: The weird world of shakes, health anxiety and illness online

Eloise Hendy asks psychologists and doctors if the viral wave of vaccine-induced symptoms is real or faked or something else entirely

The Independent UK

The Safest Stock to Buy on Wall Street Right Now

With the recent market rally hinged on hopes of an end to the Fed’s hawkishness in the foreseeable future, strong fundamentals of Pfizer (PFE) for excellent value could help investors secure decent risk-adjusted returns on their investments. Read on….

StockNews.com

3 Stocks to Buy if You're Building a Portfolio From Scratch

Shares of Pfizer (PFE), Centene (CNC), and Kellogg (K) could provide a solid foundation to new portfolios for sustained wealth creation, given the fundamental strength, consistent profitability, and resilient demand of these companies. Continue reading….

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Investors Business Daily

Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric

Biohaven is taking the same tact that led to a nearly $12 billion Pfizer buyout with the rest of its pipeline — and BHVN stock has soared.

Tribune News Service

End of public health emergency causes cascade of changes

WASHINGTON — The Biden administration’s plan to unwind the public health emergency tied to the COVID-19 pandemic will spur a whirlwind of changes related to telehealth, Medicaid, pharmaceuticals and other priorities.

Fortune

Pfizer's former CFO says you should ask yourself these questions if you want to become a finance chief

After many years as a finance chief, Frank D'Amelio, is now a strategic advisor for CFOs.

Get all your
news in one place.

100’s of premium titles.
One news app.

Roll Call

End of public health emergency causes cascade of changes - Roll Call

The public health emergency created an array of health flexibilities, impacting everything from Medicaid to telehealth coverage.

Los Angeles Times

DC boss James Gunn shrugs off 'Shazam' star Zachary Levi's anti-Pfizer tweet

DC boss James Gunn has addressed a controversial tweet from Zachary Levi that called into question the "Shazam!" star's position on vaccines.

The Independent UK

James Gunn responds to backlash surrounding Zachary Levi’s criticism of Pfizer

‘I don’t have a list of things that somebody should say because of what I think’

ABC News

Health department reviewing fifth COVID-19 vaccine. But what if you have missed a dose?

The health department is expected to make a decision on the fifth dose within weeks. Here's what we know so far.

Investors Business Daily

The Expected Covid Cliff Is Here For Pfizer — Company Calls For Steep 2023 Declines

Pfizer called for steep declines this year from its Covid vaccine and antiviral pill, but Pfizer stock reversed higher Tuesday.

Investors Business Daily

Dow Jones Reverses Lower Ahead Of Fed Meeting; Caterpillar, Exxon, Pfizer, McDonald's Fall On Earnings

The Dow Jones reversed lower Tuesday, as the Fed's two-day meeting kicks off today. Caterpillar, Exxon and Pfizer dropped on earnings.

The Street

Pfizer Stock Active As Soft Covid Vaccine Sales Outlook Mars Q4 Earnings Beat

"As we turn to 2023, we expect to once again set records, with potentially the largest number of new product and indication launches that we’ve ever had in such a short period of time," said CEO Albert Bourla.

1 … 23 24 25 26

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.